Cubist Systematic Strategies’s Nektar Therapeutics NKTR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3
Closed -$37 2242
2024
Q1
$37 Sell
3
-1,584
-100% -$19.5K ﹤0.01% 2139
2023
Q4
$13.5K Buy
1,587
+1,155
+267% +$9.79K ﹤0.01% 1958
2023
Q3
$3.86K Sell
432
-1,132
-72% -$10.1K ﹤0.01% 1849
2023
Q2
$13.5K Sell
1,564
-2,531
-62% -$21.8K ﹤0.01% 2031
2023
Q1
$43.2K Sell
4,095
-20,318
-83% -$214K ﹤0.01% 2546
2022
Q4
$828K Buy
24,413
+10,752
+79% +$365K ﹤0.01% 1887
2022
Q3
$656K Sell
13,661
-3,823
-22% -$184K ﹤0.01% 2336
2022
Q2
$997K Sell
17,484
-42,039
-71% -$2.4M 0.01% 2123
2022
Q1
$4.81M Buy
59,523
+24,433
+70% +$1.98M 0.04% 762
2021
Q4
$7.11M Buy
35,090
+24,970
+247% +$5.06M 0.07% 428
2021
Q3
$2.73M Buy
10,120
+5,892
+139% +$1.59M 0.03% 814
2021
Q2
$1.09M Sell
4,228
-2,954
-41% -$760K 0.01% 1513
2021
Q1
$2.16M Sell
7,182
-2,666
-27% -$800K 0.03% 983
2020
Q4
$2.51M Buy
9,848
+4,195
+74% +$1.07M 0.03% 805
2020
Q3
$1.41M Buy
5,653
+151
+3% +$37.6K 0.02% 1130
2020
Q2
$1.91M Buy
5,502
+3,201
+139% +$1.11M 0.03% 823
2020
Q1
$616K Sell
2,301
-740
-24% -$198K 0.02% 1122
2019
Q4
$985K Buy
3,041
+978
+47% +$317K 0.02% 1167
2019
Q3
$564K Sell
2,063
-4,613
-69% -$1.26M 0.01% 1240
2019
Q2
$3.56M Sell
6,676
-965
-13% -$515K 0.07% 413
2019
Q1
$3.85M Buy
+7,641
New +$3.85M 0.12% 206
2018
Q4
Sell
-219
Closed -$200K 2198
2018
Q3
$200K Sell
219
-251
-53% -$229K 0.01% 1397
2018
Q2
$344K Sell
470
-2,397
-84% -$1.75M 0.02% 993
2018
Q1
$4.57M Buy
+2,867
New +$4.57M 0.27% 62
2016
Q4
Sell
-1,801
Closed -$464K 1830
2016
Q3
$464K Buy
1,801
+1,007
+127% +$259K 0.03% 750
2016
Q2
$169K Buy
794
+662
+502% +$141K 0.01% 1392
2016
Q1
$27K Sell
132
-2,568
-95% -$525K ﹤0.01% 1519
2015
Q4
$682K Buy
2,700
+1,475
+120% +$373K 0.04% 663
2015
Q3
$201K Sell
1,225
-3,497
-74% -$574K 0.01% 1478
2015
Q2
$886K Buy
+4,722
New +$886K 0.04% 646
2015
Q1
Sell
-2,155
Closed -$501K 2019
2014
Q4
$501K Sell
2,155
-339
-14% -$78.8K 0.03% 858
2014
Q3
$452K Buy
2,494
+332
+15% +$60.2K 0.03% 893
2014
Q2
$416K Buy
+2,162
New +$416K 0.03% 813